Find a Tender
complete
Official procurement procedure
Terms and Conditions for the Supply of Centrally Procured Vaccines - SARS-CoV-2 VACCINE SUPPLY AGREEMENT
Vaccines
UK
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Business Energy and Industrial Strategy: "Terms and Conditions for the Supply of Centrally Procured Vaccines - SARS-CoV-2 VACCINE SUPPLY AGREEMENT". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | Business Energy and Industrial Strategy | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: Business Energy and Industrial Strategy
Market Analytics
Derived from OCDS awards & bid statistics
Published history for Business Energy and Industrial Strategy. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
2.1Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 26 active published awards; 25 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityBusiness Energy and Industrial Strategy | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published9 Sept 2021, 17:14 BST | Last source update9 Sept 2021, 17:14 BST | Recurring procurementNot published |
ClassificationVaccines | ||
Delivery area UK | ||
OCIDocds-h6vhtk-02df25 | ||
What is being bought
Procurement of the Covid-19 BNT162b2 Vaccine.
What changed
From the official release history
- Status changed to complete
9 Sept 2021, 17:14 BST - Official notice release published
9 Sept 2021, 17:14 BST - Buyer information updated
9 Sept 2021, 17:14 BST
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcancelledPublished valueNot publishedProcurement of the Covid-19 BNT162b2 Vaccine.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
9 Sept 2021, 17:14 BST - Award active
Not published · Not published - Contract active
Signed 10 Aug 2021, 00:00 BST · £1
Commercial outcome and competition
Awards Pfizer Limited Not published · Not published · active |
Contracts TERMS AND CONDITIONS FOR THE SUPPLY OF CENTRALLY PROCURED VACCINES £1 · signed 10 Aug 2021, 00:00 BST · active |
Bid statistics bids: 1 (lot 1) |
Buyer and organisations in this procedure
Business Energy and Industrial Strategy
Contracting authority GB-FTS-5606Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationaleThe award of the contract to Pfizer is strictly necessary due to absence of competition for technical reasons. Regulation 32 (b)(ii). |